Ultrasound-guided Thermal Ablation for Bethesda III/IV Thyroid Nodules
ConditionThyroid Nodule
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorChinese PLA General Hospital
About this trial
To evaluate the long-term outcomes of ultrasound-guided thermal ablation for Bethesda III/IV thyroid nodules
Eligibility criteria
Qualifiers
confirmation of Bethesda III or IV on fine- needle aspiration and negative on Braf V600E test
no clinical or imaging evidences of extrathyroidal extension, lymph node metastasis and distant metastasis on ultrasound, neck and chest CT
refusal or ineligibility for surgery
follow-up time ≥12 months
Disqualifiers
follicular neoplasm or malignancy findings on biopsy
no suspicious of malignancy in US
patients with contra-lateral vocal cord paralysis
follow- up time less than 12 months
Trial design
Treatments tested in this trial
- ultrasound-guided thermal ablation
Treatment groups
600 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov